UNIBIO Current Asset

0.196  0.0070  3.45%
Current Asset is all of company's assets that can be used to pay off current liabilities within current fiscal period or over next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset 
Liquid Assets 
255 M

About Current Asset

Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets, since these assets can be easily liquidated in case the company goes bankrupt. However it is usually not enough to know if a company is in a good shape just based on current asset alone; the amount of current liabilities should always be considered.
Compare UNIBIO to competition

UNIBIO Current Asset Assessment

In accordance with recently published financial statements UNIBIO GROUP has Current Asset of 255 M. This is 99.77% lower than that of the Consumer Goods sector, and 87.4% lower than that of Packaging and Containers industry, The Current Asset for all stocks is 98.77% higher than the company.

Filter other Stocks by Current Asset

Current Asset Input Range 
Click to run this filter
Filter Other Equities
Found 8 equities

Current Asset

0468 HKGGreatview Aseptic Packaging Company Limited
1.67 B
0377 HKGNew Island Development Holdings Limited
2.28 B
1328 HKGInternational Elite Limited
614 M
3300 HKGChina Glass Holdings Limited
2.27 B
0474 HKGHao Tian Development Group Limited
4.03 B
255 M
0572 HKGChina Packaging Group Company Limited
86 M
1201 HKGKith Holdings Ltd
468 M
You can backtest this sub-set of assets as a synthetic portfolio or check its risk adjusted returns  

Current Asset Comparison

UNIBIO is rated below average in current asset category among related companies.
InstrumentHong Kong Stock
Risk-adjusted AdviceStrong Sell Over Valued
ExchangeHong Kong Stock Exchange
DescriptionUniBio Science Group Limited an investment holding company operates in the pharmaceutical industry in the Peoples Republic of China. more

Other UNIBIO Fundamentals

Profit Margin(46.23) %
Operating Margin(49.45) %
Current Valuation977.99 M
Shares Outstanding5.05 B
Price to Book2.03 times
Price to Sales9.61 times
Revenue122.39 M
Gross Profit102 M
EBITDA(10.89 M)
Net Income(56.58 M)
Cash and Equivalents197.43 M
Cash per Share0.04 times
Current Ratio5.58 times
Book Value Per Share0.12 times
Cash Flow from Operations(79.7 M)
One Year High0.3
One Year Low0.14
Earnings Per Share(0.09) times
Number of Employees253
Market Capitalization1.21 B
Total Asset674 M
Retained Earnings(159 M)
Current Asset255 M
Current Liabilities83 M